Explore more publications!
Healthy Living South Dakota
Got News to Share?

Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 23, 2025

Umoja Biopharma Named One of 2025’s Most Promising Biotech Companies by Endpoints News and Fierce Biotech
September 23, 2025

Umoja Biopharma Named One of 2025’s Most Promising Biotech Companies by Endpoints News and Fierce Biotech

Indeterminate GlobeNewswire
Gain Therapeutics to Participate at Drug Discovery Innovation Programme 2025
September 23, 2025

Gain Therapeutics to Participate at Drug Discovery Innovation Programme 2025

Indeterminate GlobeNewswire
MariMed’s Betty’s Eddies Spreads Importance of Cancer Screening Education and Awareness through Partnership with Keep A Breast Foundation
September 23, 2025

MariMed’s Betty’s Eddies Spreads Importance of Cancer Screening Education and Awareness through Partnership with Keep A Breast Foundation

Indeterminate GlobeNewswire
Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025
September 23, 2025

Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025

Indeterminate GlobeNewswire
Altimmune to Participate in Two Upcoming Investor Conferences
September 23, 2025

Altimmune to Participate in Two Upcoming Investor Conferences

Indeterminate GlobeNewswire
Amphista Therapeutics discloses first details of its TEAD Targeted Glue™ program and unveils new mechanism of action for TEAD degradation via FBXO22
September 23, 2025

Amphista Therapeutics discloses first details of its TEAD Targeted Glue™ program and unveils new mechanism of action for TEAD degradation via FBXO22

Indeterminate GlobeNewswire
Microbix Assisting EMQN with Second Genetic-Test EQA Program
September 23, 2025

Microbix Assisting EMQN with Second Genetic-Test EQA Program

Indeterminate GlobeNewswire
Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award
September 23, 2025

Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award

Indeterminate GlobeNewswire
SEED Therapeutics Completes $30 Million Series A-3 Financing
September 23, 2025

SEED Therapeutics Completes $30 Million Series A-3 Financing

Indeterminate GlobeNewswire
BPGbio Welcomes Back NAi Interrogative Biology® Platform Co-Inventor Slava Akmaev, Ph.D., as Chief Operating Officer and Chief AI Officer
September 23, 2025

BPGbio Welcomes Back NAi Interrogative Biology® Platform Co-Inventor Slava Akmaev, Ph.D., as Chief Operating Officer and Chief AI Officer

Indeterminate GlobeNewswire
Tilray Beverages Unveils New Fall Seasonal Craft Brews with Oktoberfest-Inspired Lineup
September 23, 2025

Tilray Beverages Unveils New Fall Seasonal Craft Brews with Oktoberfest-Inspired Lineup

Indeterminate GlobeNewswire
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression
September 23, 2025

atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression

Indeterminate GlobeNewswire
BioNTech veranstaltet am 1. Oktober 2025 zweiten „AI Day“ als eine Ausgabe der „Innovation Series“
September 23, 2025

BioNTech veranstaltet am 1. Oktober 2025 zweiten „AI Day“ als eine Ausgabe der „Innovation Series“

Indeterminate GlobeNewswire
BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025
September 23, 2025

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

Indeterminate GlobeNewswire
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announced the Closing of Their Previously Announced Business Combination on September 22, 202…
September 23, 2025

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announced the Closing of Their Previously Announced Business Combination on September 22, 202…

Indeterminate GlobeNewswire
NeuraClick Welcomes Biotech Veteran Daniel M. Bradbury as Strategic and Metabolic Programs Advisor
September 23, 2025

NeuraClick Welcomes Biotech Veteran Daniel M. Bradbury as Strategic and Metabolic Programs Advisor

Indeterminate GlobeNewswire
2025 InnoMatch Tech-Matching Fair Opens in Shanghai to Push Global Sci-Tech Cooperation
September 23, 2025

2025 InnoMatch Tech-Matching Fair Opens in Shanghai to Push Global Sci-Tech Cooperation

Indeterminate GlobeNewswire
Labviva Kicks Off Smart Lab of the Future Tour
September 23, 2025

Labviva Kicks Off Smart Lab of the Future Tour

Indeterminate GlobeNewswire
Santhera gibt die Finanzergebnisse für das erste Halbjahr 2025 bekannt und informiert über aktuelle Unternehmensentwicklungen
September 23, 2025

Santhera gibt die Finanzergebnisse für das erste Halbjahr 2025 bekannt und informiert über aktuelle Unternehmensentwicklungen

Indeterminate GlobeNewswire
Santhera Announces Half Year 2025 Financial Results and Provides Corporate Update
September 23, 2025

Santhera Announces Half Year 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions